RxDoctor Payments Data

Ruth Hart

Psychiatric/Mental Health · Wichita, KSNPI 1336729888

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,260in general payments, 2019–2025

Across 306 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • AbbVie$637
  • Alkermes, Inc.$588
  • Vanda Pharmaceuticals Inc.$518
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$425
  • Neos Therapeutics, LP$397
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$5,260100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,260 in reported general payments places this provider in the 90th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$28,866
Lamotrigine ErLamotrigine12$9,238
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$4,670
Desvenlafaxine Succinate ErDesvenlafaxine Succinate64$2,119
Clonazepam12$361
Risperidone21$237
Olanzapine16$175
Venlafaxine Hcl ErVenlafaxine Hcl31$169
Hydroxyzine Hcl11$66
Trazodone Hcl12$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$637$28,86611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →